
    
      This trial is a real-world non-interventional observational study. The Chinese patients with
      thoracic T1-T3 esophageal cancer enrolled from Jan.1999 to Jun.2017 were included and the
      study data on pathologically diagnosed patient demographic/tumor biological characteristics
      were collected to evaluate the relevance of lymph metastases and prognoses of the subjects.
    
  